CAS 151250-76-9

(S)-9-Fluoro-2,3-dihydro-3-Methyl-10-[[2-(Methylamino)ethyl]amino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid

CAS : 151250-76-9

Formule : C₁₆H₁₈FN₃O₄

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 335.3302

Ref: IN-DA003AL3

(S)-9-Fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

CAS : 151250-76-9

(S)-9-Fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

Degré de pureté : 95%

Masse moléculaire : 335.34g/mol

Ref: 54-PC1003124

Levofloxacin EP Impurity G (Levofloxacin USP Related Compound E (Free Form), N,N'-Desethylene Levofloxacin)

CAS : 151250-76-9

Formule : C₁₆H₁₈FN₃O₄

Couleur et forme : Pale Yellow Solid

Masse moléculaire : 335.34

Ref: 4Z-L-237

Levofloxacin impurity

CAS : 151250-76-9

Levofloxacin is a drug product that is used to treat bacterial infections. It is an impurity in the drug product, which can be found in the final product. Levofloxacin impurity has been detected by LC-MS/MS and GC-MS analysis. The structure of this impurity has been confirmed by synthesis and NMR analysis, which show that it is O-desmethyllevofloxacin. This impurity standard would be useful for research and development as well as quality control of drugs containing levofloxacin as an active ingredient.

Formule : C₁₆H₁₈FN₃O₄

Degré de pureté : Min. 95%

Masse moléculaire : 335.33 g/mol

Ref: 3D-BGA25076